Insights

Innovative Technology Platform EmitBio utilizes a proprietary light-based technology to stimulate healing processes at the cellular level, indicating a potential market for advanced medical devices and therapeutic solutions targeting respiratory diseases and beyond.

Strategic Expansion Focus With early-stage products designed for at-home use and plans to broaden its product family, EmitBio presents opportunities for partnerships or sales in consumer health markets, telemedicine, and remote patient monitoring sectors.

Growth Potential Operating with a modest revenue range and recent funding of 2 million dollars, EmitBio shows signs of financial agility and a growth trajectory in biotech innovation, making it a promising prospect for investment or collaborative ventures.

Leadership & Public Relations Recent appointment of a global PR head suggests a focus on strategic communications and market positioning, opening doors for sales collaborations in branding, educational outreach, and market entry initiatives.

Industry Positioning As a biotech focused on respiratory health with comparative players of varying sizes, EmitBio's niche offers potential for specialized product partnerships, technology licensing, and entry into respiratory therapy markets with unmet needs.

Similar companies to EmitBio Inc.

EmitBio Inc. Tech Stack

EmitBio Inc. uses 8 technology products and services including Cloudflare CDN, oEmbed, BugHerd, and more. Explore EmitBio Inc.'s tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • oEmbed
    Dev Tools
  • BugHerd
    Issue Trackers
  • CentOS
    Operating Systems
  • Priority Hints
    Performance
  • Google Tag Manager
    Tag Management
  • Apache
    Web Servers
  • Apache HTTP Server
    Web Servers

EmitBio Inc.'s Email Address Formats

EmitBio Inc. uses at least 1 format(s):
EmitBio Inc. Email FormatsExamplePercentage
FLast@emitbio.comJDoe@emitbio.com
50%
FLast@emitbio.comJDoe@emitbio.com
50%

Frequently Asked Questions

Where is EmitBio Inc.'s headquarters located?

Minus sign iconPlus sign icon
EmitBio Inc.'s main headquarters is located at 4222 Emperor Blvd., Suite 470 Durham, North Carolina 27703, US. The company has employees across 1 continents, including North America.

What is EmitBio Inc.'s official website and social media links?

Minus sign iconPlus sign icon
EmitBio Inc.'s official website is emitbio.com and has social profiles on LinkedInCrunchbase.

What is EmitBio Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
EmitBio Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does EmitBio Inc. have currently?

Minus sign iconPlus sign icon
As of November 2025, EmitBio Inc. has approximately 11 employees across 1 continents, including North America. Key team members include Chief Executive Officer: B. S.Chief Medical Officer: J. M.Chief Medical Officer: J. M.. Explore EmitBio Inc.'s employee directory with LeadIQ.

What industry does EmitBio Inc. belong to?

Minus sign iconPlus sign icon
EmitBio Inc. operates in the Biotechnology Research industry.

What technology does EmitBio Inc. use?

Minus sign iconPlus sign icon
EmitBio Inc.'s tech stack includes Cloudflare CDNoEmbedBugHerdCentOSPriority HintsGoogle Tag ManagerApacheApache HTTP Server.

What is EmitBio Inc.'s email format?

Minus sign iconPlus sign icon
EmitBio Inc.'s email format typically follows the pattern of FLast@emitbio.com. Find more EmitBio Inc. email formats with LeadIQ.

How much funding has EmitBio Inc. raised to date?

Minus sign iconPlus sign icon
As of November 2025, EmitBio Inc. has raised $2M in funding. The last funding round occurred on Nov 08, 2022 for $2M.

When was EmitBio Inc. founded?

Minus sign iconPlus sign icon
EmitBio Inc. was founded in 2020.

EmitBio Inc.

Biotechnology ResearchUnited States11-50 Employees

EmitBio™ is a biotechnology company with products in the discovery, pre-clinical, and clinical stages of development.  The Company’s proprietary technology platform uses precisely engineered light to stimulate physiological signals and initiate healing at the cellular level.  While initially focused on an at-home treatment for COVID-19, EmitBio targets to deploy a family of products to redefine the standard of care for respiratory disease.  

EmitBio Inc. is headquartered in Durham, North Carolina and is an operating subsidiary of KNOW Bio, LLC.

Section iconCompany Overview

Headquarters
4222 Emperor Blvd., Suite 470 Durham, North Carolina 27703, US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2020
Employees
11-50

Section iconFunding & Financials

  • $2M

    EmitBio Inc. has raised a total of $2M of funding over 1 rounds. Their latest funding round was raised on Nov 08, 2022 in the amount of $2M.

  • $1M$10M

    EmitBio Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $2M

    EmitBio Inc. has raised a total of $2M of funding over 1 rounds. Their latest funding round was raised on Nov 08, 2022 in the amount of $2M.

  • $1M$10M

    EmitBio Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.